Orphan receptor promiscuity in the induction of cytochromes P450 by xenobiotics

被引:86
|
作者
Smirlis, D
Muangmoonchai, R
Edwards, M
Phillips, IR
Shephard, EA
机构
[1] Queen Mary Univ London, Sch Biol Sci, London E1 4NS, England
[2] UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England
关键词
D O I
10.1074/jbc.M005930200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanisms by which different classes of chemicals induce the same cytochrome P450 (CYP) or the same chemical differentially induces more than one CYP are not well understood. We show that in primary hepatocytes and in vivo in liver (transfected by particle-mediated delivery) two orphan nuclear receptors, constitutive androstane receptor and pregnane X receptor (PXR1), transactivate a CYP gene via the same response element in a xenobiotic-specific manner. The constitutive androstane receptor mediates the barbiturate activation of expression of CYP2B1 and CYP3A1. PXR1 activates both genes in response to synthetic steroids. To exert their effect the receptors bind to the same direct repeat site (DR4) within the phenobarbital response element of the CYP2B1 promoter and to the same DR3 site in the pregnane X response element of CYP3A1. The receptors are therefore promiscuous with respect to DNA binding but not ligand binding. Differences in enhancer half-site spacing may influence the efficiency of interactions between the receptor and the transcription machinery and hence form the basis for the differential induction of CYP2B1 and CYP3A1 in response to barbiturates and synthetic steroids.
引用
收藏
页码:12822 / 12826
页数:5
相关论文
共 50 条
  • [31] Cytochromes P450 and human health
    Stiborová, M
    Hudecek, I
    Hodek, P
    Frei, E
    CHEMICKE LISTY, 1999, 93 (04): : 229 - 237
  • [32] Structural Biology of Cytochromes P450
    Williams, Pamela A.
    Cosme, Jose
    Vinkovic, Dijana Matak
    Ward, Alison
    Angove, Hayley
    Day, Phil
    Jhoti, Harren
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2005, 61 : C66 - C66
  • [33] Cytochromes P450: a success story
    Danièle Werck-Reichhart
    René Feyereisen
    Genome Biology, 1 (6)
  • [34] The biodiversity of microbial cytochromes P450
    Kelly, SL
    Lamb, DC
    Jackson, CJ
    Warrilow, AGS
    Kelly, DE
    ADVANCES IN MICROBIAL PHYSIOLOGY, VOL 47, 2003, 47 : 131 - 186
  • [35] Prokaryotic cytochromes P450 (Review)
    L. E. Khmelevtsova
    I. S. Sazykin
    M. A. Sazykina
    E. Yu. Seliverstova
    Applied Biochemistry and Microbiology, 2017, 53 : 401 - 409
  • [36] Cooperative properties of cytochromes P450
    Denisov, Ilia G.
    Frank, Daniel J.
    Sligar, Stephen G.
    PHARMACOLOGY & THERAPEUTICS, 2009, 124 (02) : 151 - 167
  • [37] Clinical importance of the cytochromes P450
    Nebert, DW
    Russell, DW
    LANCET, 2002, 360 (9340): : 1155 - 1162
  • [38] CYTOCHROMES P450 EXPRESSION SYSTEMS
    GONZALEZ, FJ
    KORZEKWA, KR
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1995, 35 : 369 - 390
  • [39] Cytochromes P450 as versatile biocatalysts
    Bernhardt, Rita
    JOURNAL OF BIOTECHNOLOGY, 2006, 124 (01) : 128 - 145
  • [40] Pig and minipig cytochromes P450
    Anzenbacher, P
    Anzenbacherová, E
    Zuber, R
    Soucek, P
    Guengerich, FP
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (01) : 100 - 100